Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


06.02.2017

1 Am J Med Genet B Neuropsychiatr Genet
3 Am J Psychiatry
1 Compr Psychiatry
2 J Clin Psychopharmacol
2 J Nerv Ment Dis
1 Med J Aust
1 Neuropsychology
1 Neuropsychopharmacology
8 Psychiatry Res
11 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Med Genet B Neuropsychiatr Genet

  1. THOMPSON CA, Karelis J, Middleton FA, Gentile K, et al
    Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Am J Med Genet B Neuropsychiatr Genet. 2017 Jan 31. doi: 10.1002/ajmg.b.32515.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  2. NIEMELA S, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, et al
    Data Selection Importance in the Study of the Association Between Maternal Smoking During Pregnancy and Schizophrenia: Response to Meier et al.
    Am J Psychiatry. 2017;174:188.
    PubMed     Text format    

  3. ESSOCK SM
    When Social and Environmental Adversity Causes Schizophrenia.
    Am J Psychiatry. 2017;174:89-90.
    PubMed     Text format    

  4. MEIER SM, Mors O, Parner E
    Familial Confounding of the Association Between Maternal Smoking During Pregnancy and Schizophrenia.
    Am J Psychiatry. 2017;174:187.
    PubMed     Text format    


    Compr Psychiatry

  5. SEVILLA-LLEWELLYN-JONES J, Cano-Dominguez P, de-Luis-Matilla A, Penuelas-Calvo I, et al
    Personality traits and psychotic symptoms in recent onset of psychosis patients.
    Compr Psychiatry. 2017;74:109-117.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  6. CITROME L
    Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm.
    J Clin Psychopharmacol. 2017 Jan 30. doi: 10.1097/JCP.0000000000000665.
    PubMed     Text format     Abstract available

  7. MOROZOVA M, Burminskiy D, Rupchev G, Lepilkina T, et al
    5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).
    J Clin Psychopharmacol. 2017 Jan 30. doi: 10.1097/JCP.0000000000000673.
    PubMed     Text format     Abstract available


    J Nerv Ment Dis

  8. GAN JL, Duan HF, Cheng ZX, Yang JM, et al
    Neuroprotective Effect of Modified Electroconvulsive Therapy for Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study.
    J Nerv Ment Dis. 2017 Jan 30. doi: 10.1097/NMD.0000000000000652.
    PubMed     Text format     Abstract available

  9. PINKHAM AE, Kelsven S, Kouros C, Harvey PD, et al
    The Effect of Age, Race, and Sex on Social Cognitive Performance in Individuals With Schizophrenia.
    J Nerv Ment Dis. 2017 Jan 30. doi: 10.1097/NMD.0000000000000654.
    PubMed     Text format     Abstract available


    Med J Aust

  10. KRITHARIDES L, Chow V, Lambert TJ
    Cardiovascular disease in patients with schizophrenia.
    Med J Aust. 2017;206:91-95.
    PubMed     Text format     Abstract available


    Neuropsychology

  11. BUONOCORE M, Bosia M, Bechi M, Spangaro M, et al
    Is Longer Treatment Better? A Comparison Study of 3 Versus 6 Months Cognitive Remediation in Schizophrenia.
    Neuropsychology. 2017 Feb 2. doi: 10.1037/neu0000347.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  12. PEREZ VB, Tarasenko M, Miyakoshi M, Pianka ST, et al
    Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.
    Neuropsychopharmacology. 2017 Jan 31. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    Psychiatry Res

  13. WANG J, Liu Q, Wydell TN, Liao J, et al
    Electrophysiological basis of reading related phonological impairment in Chinese speakers with schizophrenia: An ERP study.
    Psychiatry Res. 2017;261:65-71.
    PubMed     Text format     Abstract available

  14. GORCZYNSKI P, Firth J, Stubbs B, Rosenbaum S, et al
    Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis.
    Psychiatry Res. 2017;250:17-24.
    PubMed     Text format     Abstract available

  15. MANE A, Berge D, Penzol MJ, Parellada M, et al
    Cannabis use, COMT, BDNF and age at first-episode psychosis.
    Psychiatry Res. 2017;250:38-43.
    PubMed     Text format     Abstract available

  16. YOSHIMURA B, Yada Y, So R, Takaki M, et al
    The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
    Psychiatry Res. 2017;250:65-70.
    PubMed     Text format     Abstract available

  17. BONFILS KA, Lysaker PH, Minor KS, Salyers MP, et al
    Empathy in schizophrenia: A meta-analysis of the Interpersonal Reactivity Index.
    Psychiatry Res. 2016;249:293-303.
    PubMed     Text format     Abstract available

  18. HELLE S, Loberg EM, Gjestad R, Schnakenberg Martin AM, et al
    The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition.
    Psychiatry Res. 2017;250:92-98.
    PubMed     Text format     Abstract available

  19. KINCAID DL, Doris M, Shannon C, Mulholland C, et al
    What is the prevalence of autism spectrum disorder and ASD traits in psychosis? A systematic review.
    Psychiatry Res. 2017;250:99-105.
    PubMed     Text format     Abstract available

  20. GROVER S, Chakrabarti S, Hazari N, Avasthi A, et al
    Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Psychiatry Res. 2017;249:349-353.
    PubMed     Text format     Abstract available


    Schizophr Res

  21. KESHAVAN MS, Sudarshan M
    Deep dreaming, aberrant salience and psychosis: Connecting the dots by artificial neural networks.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30029.
    PubMed     Text format     Abstract available

  22. CHANG X, Collin G, Xi Y, Cui L, et al
    Resting-state functional connectivity in medication-naive schizophrenia patients with and without auditory verbal hallucinations: A preliminary report.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30037.
    PubMed     Text format     Abstract available

  23. HARBER L, Takeuchi H, Borlido C, Hamidian R, et al
    Factors associated with drug attitude in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30046.
    PubMed     Text format    

  24. FILATOVA S, Koivumaa-Honkanen H, Hirvonen N, Freeman A, et al
    Early motor developmental milestones and schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30042.
    PubMed     Text format     Abstract available

  25. ZENG L, Kang C, Yuan J, Zhang Y, et al
    CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.
    Schizophr Res. 2017 Jan 26. pii: S0920-9964(17)30043.
    PubMed     Text format    

  26. JOSEPH J, Kremen WS, Franz CE, Glatt SJ, et al
    Predictors of current functioning and functional decline in schizophrenia.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30051.
    PubMed     Text format     Abstract available

  27. ALONSO-SOLIS A, Vives-Gilabert Y, Portella MJ, Rabella M, et al
    Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30055.
    PubMed     Text format     Abstract available

  28. HENGARTNER MP, Heekeren K, Dvorsky D, Walitza S, et al
    Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30053.
    PubMed     Text format     Abstract available

  29. GREENLAND-WHITE SE, Ragland JD, Niendam TA, Ferrer E, et al
    Episodic memory functions in first episode psychosis and clinical high risk individuals.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30048.
    PubMed     Text format     Abstract available

  30. BARR MS, Rajji TK, Zomorrodi R, Radhu N, et al
    Impaired theta-gamma coupling during working memory performance in schizophrenia.
    Schizophr Res. 2017 Jan 29. pii: S0920-9964(17)30057.
    PubMed     Text format     Abstract available

  31. EMSLEY R, Chiliza B, Asmal L, Kilian S, et al
    Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30047.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: